Bausch Health Companies Inc.BHC

Market cap
$2.5B
P/E ratio
Dec 31,
2010
Dec 31,
2011
Dec 31,
2012
Dec 31,
2013
Dec 31,
2014
Dec 31,
2015
Dec 31,
2016
Dec 31,
2017
Dec 31,
2018
Dec 31,
2019
Dec 31,
2020
Dec 31,
2021
Dec 31,
2022
Dec 31,
2023
Product sales--------8,2718,4897,9248,3428,0468,663
Other revenues--------109112103927894
Revenues1,1812,4633,5475,7708,26410,4479,6748,7248,3808,6018,0278,4348,1248,757
Product sales--------2,3092,2972,2022,3612,3362,519
Other revenues--------425347332840
Selling, general and administrative2775727561,3052,0262,7002,8102,5822,4732,5542,3672,6242,6252,917
Research and development686679157246334421361413471452465529604
Amortization of intangible assets--------2,6441,8971,6451,3751,2151,077
Goodwill impairments-----------469824493
Asset Impairment Charges12-----422714568751142341554
Restructuring, integration, separation and IPO costs-----------506362
Other expense, net----269-256-35321-1,414-454-373-35-28
Total Expenses1,2912,1633,4676,1796,2248,91910,2408,62210,7648,8047,3517,9847,6707,794
Operating income-11030080-4102,0401,527-566102-2,384-203676450454963
Interest income14685381211121371426
Interest expense---------1,6121,5341,4261,4641,328
Gain (loss) on extinguishment of debt-32-37-20-65-130-20--122-119-42-59-628751
Foreign exchange and other12720-9-144-103-41107238-307-8-52
Loss before income taxes--18-394-1,3141,093-155-2,435-1,741-4,154-1,837-934-1,024-129-390
(Provision for) benefit from income taxes-28-178-278-451180133-27-4,145-10-54-375-8783221
Net loss-208---864912-288-2,4082,404-4,144-1,783-559-937-212-611
Net loss (income) attributable to noncontrolling interest---2-141-4511113-19
Net loss attributable to Bausch Health Companies Inc.-208---864912-288-2,4082,404-4,144-1,783-559-937-212-592
Earnings Per Share, Basic-1.060.52-0.38-2.72.72-0.85-6.946.86-11.81-5.08--2.64-0.62-1.62
Earnings Per Share, Diluted-1.060.49-0.38-2.72.67-0.85-6.946.83-11.81-5.08--2.64-0.62-1.62